Question 1

What is the catalog number for 3`UTR clone of tenascin XB (TNXB) transcript variant XB for miRNA target validation?

Accepted Answer

The catalog number for 3`UTR clone of tenascin XB (TNXB) transcript variant XB for miRNA target validation is SC202436.

Question 2

Is 3`UTR clone of tenascin XB (TNXB) transcript variant XB for miRNA target validation in stock?

Accepted Answer

3`UTR clone of tenascin XB (TNXB) transcript variant XB for miRNA target validation is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

What is the shelf life of this product?

Accepted Answer

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

Question 4

What expression system was used for this recombinant protein?

Accepted Answer

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

Question 5

Can I return this product if I ordered the wrong one?

Accepted Answer

As a consumer, you have a 14-day right of withdrawal from receipt under EU consumer protection law, submitted via our withdrawal/cancellation request form. Note this applies to unused, undamaged products, and doesn’t override the expiry/storage conditions on performance-based claims.

3`UTR clone of tenascin XB (TNXB) transcript variant XB for miRNA target validation

Product Specifications

Frequently Asked Questions

Explore Other Products

ALDH2 Recombinant Mouse Monoclonal Antibody [E4-D10-R]

BCL10 (MALT-Lymphoma Marker) (151), CF647 conjugate, 0.1mg/mL

Caldesmon, HMW (h-Caldesmon) (Smooth Muscle Marker) (CALD1/1424R), CF640R conjugate, 0.1mg/mL

Anti-CHX10/VSX2 Antibody Picoband® (Dylight488 Conjugate)

CD2 (LFA2/600), CF647 conjugate, 0.1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2784), CF568 conjugate, 0.1mg/mL